{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:44:44Z","timestamp":1792356284991,"version":"4.4.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1053\/j.seminoncol.2003.10.016","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T13:58:14Z","timestamp":1131026294000},"page":"4-21","source":"Crossref","is-referenced-by-count":29,"title":["Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy\u2014from bench to patient bedside"],"prefix":"10.1053","volume":"31","author":[{"given":"Shimon","family":"Slavin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana","family":"Morecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuven","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2003.10.016_BIB1","first-page":"36","article-title":"Prolongation and prevention of Rauscher virus mouse leukemia by spleen cells of naturally resistant or actively immunized mice","volume":"13","author":"Sinkovics","year":"1965","journal-title":"Clin Res"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB2","first-page":"1140","article-title":"Time pattern of the antileukemia effect of graft-versus-host reaction in mice, I. Cellular events","volume":"31","author":"Boranic","year":"1971","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","article-title":"Antileukemic effect of chronic graft-versus-host disease","volume":"304","author":"Weiden","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB4","first-page":"248","article-title":"Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation","volume":"13","author":"Weiden","year":"1981","journal-title":"Transplantation"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/281490a0","article-title":"Graft-versus-leukaemia reactivity induced by alloimmunization without augmentation of graft-versus-host reactivity","volume":"281","author":"Bortin","year":"1979","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00199267","article-title":"Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI)","volume":"11","author":"Slavin","year":"1981","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB7","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.4049\/jimmunol.131.4.2050","article-title":"Characterization of alloimmunization-induced T lymphocytes reactivated against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo","volume":"131","author":"Truitt","year":"1983","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00007890-198304000-00023","article-title":"Possibility of graft-vs-leukemia determinants independent of the major histocompatibility complex in allogeneic marrow transplantation","volume":"35","author":"Meredith","year":"1983","journal-title":"Transplantation"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4049\/jimmunol.132.2.997","article-title":"Anti-tumor effects of allogeneic bone marrow transplantation in (NZB x NZW)F1 hybrids with spontaneous lymphosarcoma","volume":"132","author":"Moscovitch","year":"1984","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/272624a0","article-title":"Spontaneous murine B-cell leukemia","volume":"272","author":"Slavin","year":"1978","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB11","first-page":"4162","article-title":"Ultrastructural, cell membrane and cytogenetic characteristics of B-cell leukemia (BCL1), a murine model of chronic lymphocytic leukemia","volume":"41","author":"Slavin","year":"1981","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB12","first-page":"196","article-title":"Enhancement of graft versus leukemia effect (GVL) with recombinant human interleukin 2 (rIL-2) following bone marrow transplantation in a murine model for acute myeloid leukemia in SJL\/J mice","volume":"23","author":"Vourka-Karussis","year":"1995","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB13","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4049\/jimmunol.132.2.997","article-title":"Anti-tumor effects of allogeneic bone marrow transplantation in (NZB x NZW)F1 hybrids with spontaneous lymphosarcoma","volume":"132","author":"Moscovitch","year":"1984","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<59::AID-IJC11>3.0.CO;2-4","article-title":"Induction of graft vs tumor effect in a murine model of mammary adenocarcinoma","volume":"71","author":"Morecki","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB15","first-page":"3891","article-title":"Allogeneic cell therapy for a murine mammary carcinoma","volume":"58","author":"Morecki","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002371-200103000-00005","article-title":"Cell therapy with pre-immunized effector cells mismatched for minor histocompatible antigens, in the treatment of a murine mammary carcinoma","volume":"24","author":"Morecki","year":"2001","journal-title":"J Immunother"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0301-472X(01)00759-7","article-title":"Non-myeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in pre-clinical models","volume":"30","author":"Prigozhina","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00199267","article-title":"Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI)","volume":"11","author":"Slavin","year":"1981","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.147.4.963","article-title":"Transplantation of allogeneic bone marrow without graft vs host disease using total lymphoid irradiation","volume":"147","author":"Slavin","year":"1978","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/07357909209032785","article-title":"Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders. I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL2-activated cell-mediated immunotherapy","volume":"10","author":"Weiss","year":"1992","journal-title":"Cancer Invest"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB21","first-page":"229","article-title":"Effect of cyclosporine A and methylprednisolone on the GVL effect across major histocompatibility barriers in mice following allogeneic bone marrow transplantation","volume":"6","author":"Weiss","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB22","first-page":"457","article-title":"The role of antibodies to IL-2 receptor and anti-Asialo GMI antibodies on GVL effects induced by BMT in murine B cell leukemia","volume":"16","author":"Weiss","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB23","first-page":"145","article-title":"Alloimmune-mediated GVL effects induced by unmodified and in vitro r-IL2 activated bone marrow and lymphocytes from different lymphoid compartments","volume":"5","author":"Weiss","year":"1999","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB24","first-page":"802","article-title":"Induction of cell-mediated IL2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation","volume":"23","author":"Slavin","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.bmt.1704150","article-title":"Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to up-regulate anti-tumor effects and down-regulate anti-host responses","volume":"32","author":"Ji","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002371-200103000-00005","article-title":"Cell therapy with pre-immunized effector cells mismatched for minor histocompatible antigens, in the treatment of a murine mammary carcinoma","volume":"24","author":"Morecki","year":"2001","journal-title":"J Immunother"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB27","first-page":"180","article-title":"Adoptive immunotherapy in conjunction with bone marrow transplantation\u2014Amplification of natural host defence mechanisms against cancer by recombinant IL2","volume":"7","author":"Slavin","year":"1988","journal-title":"Nat Immun Cell Growth Regul"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB28","series-title":"Premalignancy and Tumor Dormancy","first-page":"137","article-title":"Tumor dormancy induced by immune effector mechanisms in a murine model of B cell leukemia\/lymphoma (BCL1)","author":"Morecki","year":"1996"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB29","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","article-title":"Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia","volume":"73","author":"Sullivan","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB30","first-page":"2989","article-title":"Graft-vs-leukemia reactions in humans","volume":"21","author":"Ringden","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB32","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V88.4.1501.bloodjournal8841501","article-title":"Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer","volume":"88","author":"Eibl","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB33","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(05)65517-1","article-title":"Graft vs tumor and graft vs leukemia in patient with concurrent breast cancer and acute myelocytic leukemia","volume":"348","author":"Ben-Yosef","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1200\/JCO.1998.16.3.986","article-title":"Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer","volume":"16","author":"Ueno","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB35","first-page":"1","article-title":"Allogeneic cell mediated immunotherapy for breast cancer after autologous stem cell transplantation","volume":"4","author":"Or","year":"1998","journal-title":"Cytokines Cell Mol Ther"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB36","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.1999.17.7.2044","article-title":"Successful treatment of metastatic renal cell carcinoma with a non-myeloablative allogeneic peripheral-blood progenitor-cell transplant","volume":"17","author":"Childs","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB37","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM200009143431101","article-title":"Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation","volume":"11","author":"Childs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB38","first-page":"96","article-title":"Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes","volume":"19","author":"Kapelushnik","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00043426-199803000-00011","article-title":"Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic BMT for beta thalassemia major","volume":"20","author":"Aker","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00075200-199909000-00002","article-title":"Minitransplants and cell-based therapies for malignant and non-malignant disorders","volume":"4","author":"Slavin","year":"1999","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB41","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","article-title":"Graft vs autoimmune lymphocytes (GVA) following allogeneic bone marrow transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis","volume":"28","author":"Slavin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","article-title":"Graft vs autoimmune lymphocytes (GVA) following allogeneic bone marrow transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis","volume":"28","author":"Slavin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB44","first-page":"407a","article-title":"Cellular-mediated immunotherapy of leukemia in conjunction with autologous and allogeneic bone marrow transplantation in experimental animals and man","volume":"72","author":"Slavin","year":"1988","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/j.seminoncol.2003.10.016_BIB45","first-page":"208","article-title":"Prevention of GVHD and induction of graft vs leukemia (GVL) effects","volume":"3","author":"Slavin","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB46","first-page":"566a","article-title":"Cell-mediated cytokine-activated immunotherapy (CCI) of malignant hematological disorders for eradication of minimal residual disease (MRD) in conjunction with conventional chemotherapy or bone marrow transplantation (BMT)","volume":"76","author":"Slavin","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB47","first-page":"1553","article-title":"Allogeneic cell therapy for relapsed leukemia following bone marrow transplantation with donor peripheral blood lymphocytes","volume":"23","author":"Slavin","year":"1995","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB48","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","article-title":"Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse post allogeneic bone marrow transplantation","volume":"87","author":"Slavin","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB49","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1995.tb08356.x","article-title":"T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor\u2019s peripheral blood lymphocytes for prevention of relapse","volume":"89","author":"Naparstek","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB50","series-title":"Clinical Transplants","first-page":"281","article-title":"Allogeneic cell mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic BMT for hematological malignancies","author":"Naparstek","year":"1996"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB51","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V77.7.1423.1423","article-title":"Increased risk of leukemia relapse with high dose cyclosporine A after allogeneic marrow transplantation for acute leukemia","volume":"77","author":"Bacigalupo","year":"1991","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB52","first-page":"164","article-title":"Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT)","volume":"6","author":"Slavin","year":"1992","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB53","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusion for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","article-title":"Bone marrow transplantation for chronic myelogenous leukemia in chronic phase","volume":"108","author":"Goldman","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.1993.11.3.513","article-title":"Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation","volume":"11","author":"Bar","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB56","first-page":"405","article-title":"Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation","volume":"12","author":"Leber","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB57","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V82.8.2310.2310","article-title":"Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation","volume":"82","author":"Drobyski","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM199401133300204","article-title":"Induction of graft versus host disease for relapsed chronic myeloid leukemia","volume":"330","author":"Porter","year":"1994","journal-title":"N Eng J Med"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB59","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation","volume":"86","author":"Mackinnon","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB60","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lympho-proliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB61","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-2249.1996.d01-619.x","article-title":"Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus specific cytotoxic T lymphocytes from an HLA matched sibling to a patient with severe chronic active EBV infection","volume":"103","author":"Kuzushima","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/346245a0","article-title":"A gene mapping to the sex-determining region of the mouse y chromosome is a member of a novel family of embryologically expressed genes","volume":"346","author":"Gubbay","year":"1990","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB65","first-page":"273","article-title":"Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT","volume":"17","author":"Pugatsch","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB66","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2141.1997.4683272.x","article-title":"The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation","volume":"99","author":"Raanani","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB67","first-page":"329","article-title":"Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease","volume":"11","author":"Johnson","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB68","first-page":"561","article-title":"Adoptive immunotherapy in human and canine chimeras","volume":"12","author":"Kolb","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 2a","key":"10.1053\/j.seminoncol.2003.10.016_BIB69","first-page":"S83","article-title":"Clinical experience with fludarabine in hemato-oncology","volume":"38","author":"Keating","year":"1996","journal-title":"Hematol Cell Ther"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB70","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V92.4.1165","article-title":"Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy","volume":"92","author":"Keating","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB71","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non malignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB72","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB73","first-page":"1853a","article-title":"Preliminary results of fludarabine\/melphalan or 2CDA\/melphalan as preparative regimens for allogeneic progenitor cell transplantation in poor candidates for conventional myeloablative conditioning","volume":"90","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB74","first-page":"519a","article-title":"Outpatient PBSC allografts using immunosuppression with low-dose TBI before, and cyclosporine (CSP) and mycophenolate mofetil (MMF) after transplant","volume":"92","author":"McSweeney","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB75","first-page":"304","article-title":"Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia","volume":"85","author":"Carella","year":"2000","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB76","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1702204","article-title":"\u201cMini-allografts\u201d","volume":"25","author":"Carella","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB77","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/sj.bmt.1701165","article-title":"Bone marrow transplatation from a cadaveric donor","volume":"21","author":"Kapelushnik","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1701903","article-title":"Donor lymphocyte infusion post non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease","volume":"24","author":"Nagler","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB79","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bmt.1701016","article-title":"Fludarabine based protocol for BMT in Fanconi anemia","volume":"29","author":"Kapelushnik","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB80","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00043426-199905000-00013","article-title":"Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi\u2019s anemia","volume":"21","author":"Aker","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bmt.1702392","article-title":"Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for a malignant lymphoma","volume":"25","author":"Nagler","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB82","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(00)00172-7","article-title":"Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis","volume":"28","author":"Slavin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB83","first-page":"81","article-title":"Treatment of myeloid leukemias with non-myeloablative stem cell transplantation: Accomplishments and future goals. Educational Symposium, ASH, December 2000","volume":"1","author":"Slavin","year":"2000","journal-title":"Hematology"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0301-472X(00)00655-X","article-title":"Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation","volume":"29","author":"Nagler","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB85","first-page":"1857a","article-title":"Induction of graft-versus-leukemia as primary treatment of chronic myelogenous leukemia","volume":"90","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB86","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood.V86.11.4337.bloodjournal86114337","article-title":"CD8-depleted donor lymphocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation","volume":"86","author":"Giralt","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB87","first-page":"1853a","article-title":"Preliminary results of fludarabine\/melphalan or 2CDA\/melphalan as preparative regimens for allogeneic progenito cell transplantation in poor candidates for conventional myeloablative conditioning","volume":"90","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB88","first-page":"904","article-title":"Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias","volume":"83","author":"Carella","year":"1998","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB89","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2141.1998.01057.x","article-title":"Evidence of cytogenetic and molecular remission by allogeneic cells after immunosuppressive therapy alone","volume":"103","author":"Carella","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB90","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1182\/blood.V86.11.4376.bloodjournal86114376","article-title":"DLA-identical bone marrow grafts after low-dose total body irradiation","volume":"86","author":"Yu","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB91","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood.V89.8.3048","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation","volume":"89","author":"Storb","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB92","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V94.3.1131.415k21_1131_1136","article-title":"Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given lymph node irradiation before and pharmacological immunosuppression after marrow transplantation","volume":"90","author":"Storb","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB93","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/bbmt.1999.v5.pm10392959","article-title":"Lymphohematopoietic graft-vs-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based non-myeloablative conditioning regimen","volume":"5","author":"Pelot","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB94","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)11135-2","article-title":"Mixed lymphohematopoietic chimerism and graft-vs-lymphoma effects are achievable in adult recipients following non-myeloablative therapy and HLA-mismatched donor bone marrow transplantation","volume":"353","author":"Sykes","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2003.10.016_BIB95","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00002371-200103000-00005","article-title":"Cell therapy with pre-immunized effector cells mismatched for minor histocompatible antigens, in the treatment of a murine mammary carcinoma","volume":"24","author":"Morecki","year":"2001","journal-title":"J Immunother"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403005591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775403005591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T08:21:21Z","timestamp":1683274881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775403005591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0093775403005591"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2003.10.016","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}